USPTO serial 86357405
Serial No. 86357405
Reviewed by CopyMark Law Group
Reg. 4829924Status 710
- Filing date
- Status date
- Registration date
- Oct 13, 2015
- Examiner
- BLANDU, FLORENTINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 86357405?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Santhera Pharmaceuticals Holding AG
Pratteln, CH
Other trademarks owned by Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals Holding AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon,
PATRICK J. CONCANNON, Locke Lord LLPPO BOX 1470Church Street StationNEW YORK, NY 10008-1470Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of central nervous system-related conditions, ophthalmological diseases and neuromuscular diseases; pharmaceutical preparations for the treatment of ataxia, muscular dystrophies, Lou Gehrig's disease, Parkinson, Huntington disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; veterinary preparations for the treatment of central nervous system-related conditions, ophthalmological diseases and neuromuscular diseases; sanitary preparations for medical use; dietetic foods, namely, food and beverage supplements and nutritional supplements adapted for medical use | SECTION 8 - CANCELLED | — |
| 009 | Scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computer hardware and software, for use with medical patient monitoring equipment, for measuring, receiving, processing, transmitting and displaying data; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computers, gamma cameras, collimators, aperture plates and computer software, all sold together as a unit for use in measuring the physical and mental condition of individuals affected by ataxia, muscular dystrophies, Lou Gehrig's disease, Parkinson, Huntington disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use | SECTION 8 - CANCELLED | — |
| 010 | Surgical and medical apparatus and instruments for use in general surgery | SECTION 8 - CANCELLED | — |
| 016 | Printed informational cards in the field of pharmaceuticals; printed publications, namely, newsletters, case studies, and white papers in the fields of pharmaceuticals, central nervous system-related conditions, ophthalmological diseases, and neuromuscular diseases | SECTION 8 - CANCELLED | — |
| 042 | Pharmaceutical research and development services; chemical analysis for the pharmaceutical industry; scientific research and development; scientific research, namely, conducting clinical trials; providing scientific research information in the field of pharmaceuticals and clinical trials | SECTION 8 - CANCELLED | — |
| 044 | Hygienic and beauty care for human beings or animals, namely, providing health, medical and pharmaceutical information, consultancy and advisory services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Santhera Pharmaceuticals Holding AG
- Other trademarks owned by Santhera Pharmaceuticals Holding AG
- Other trademarks owned by Santhera Pharmaceuticals Holding AG
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 29, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 13, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 20, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 20, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 26, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 13, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 28, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 20, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 19, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 7, 2015 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 21, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 18, 2015 | ALIE | ASSIGNED TO LIE | — |
| Feb 27, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2014 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 13, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2014 | NWAP | NEW APPLICATION ENTERED | — |